BOULDER PHARMACEUTICALS MOUNJABOUL/TIRZEPATIDE PEPTIDO
Boulder Pharmaceuticals Mounjaboul is a therapeutic peptide based on Tirzepatide designed to support appetite control, energy metabolism, and body composition.
- The description claims that Tirzepatide acts as a dual agonist of GLP-1 and GIP receptors.
Variants (1)
- Default Title — 650.00 GTQ — In stock
AI Readiness
Good foundation, but some important product data is still missing.
77%